Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
Some studies have shown that rifaximin is effective in the management of Crohn\'s Disease. Meanwhile, its adverse effect is tolerable. But no study has been conducted to assess its effect on preventing postoperative recurrence. Thus, we conduct a randomised controlled study to assess the effect of rifaximin combined with thiopurine on preventing postoperative endoscopic recurrence in Crohn\'s disease, compared with thiopurine. The primary endpoint is the rate of endoscopic recurrence at 6 months.
Epistemonikos ID: ec508bcbdb6848beb7678bba17c4ba7a04610351
First added on: May 20, 2024